Cell therapy for end-stage liver disease: Current state and clinical challenge
Abstract. Liver disease involves a complex interplay of pathological processes, including inflammation, hepatocyte necrosis, and fibrosis. End-stage liver disease (ESLD), such as liver failure and decompensated cirrhosis, has a high mortality rate, and liver transplantation is the only effective tre...
Saved in:
| Main Authors: | Lin Zhang, Yuntian Deng, Xue Bai, Xiao Wei, Yushuang Ren, Shuang Chen, Hongxin Deng, Yanjie Yin |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer
2024-12-01
|
| Series: | Chinese Medical Journal |
| Online Access: | http://journals.lww.com/10.1097/CM9.0000000000003332 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effectiveness and safety evaluation of terlipressin in the treatment of intestinal paralysis in end-stage liver disease
by: Xia Wan, et al.
Published: (2025-04-01) -
End-stage kidney disease patients during the current Gaza war: challenges and outcomes of care
by: Joslin AlDadah, et al.
Published: (2025-07-01) -
Correction: Cellular Senescence in Livers from Children with End Stage Liver Disease
Published: (2010-01-01) -
End-stage Ankle Arthritis: Variations in the Current State of Practice of Asia-Pacific Foot and Ankle Surgeons
by: Chin Yik Tan, et al.
Published: (2023-07-01) -
Current Status and Challenges of Ultrasound-Guided Ablation Therapy for Liver Cancer
by: Yan ZHOU, et al.
Published: (2025-04-01)